57 results
CORRESP
GYRE
Gyre Therapeutics Inc
26 Jun 23
Correspondence with SEC
12:00am
was the recruitment of a sufficient number of patients for the trial. However, Hydronidone targets a patient population with liver fibrosis that is larger in scale … the preparatory measures it intends to undertake prior to the launch of Hydronidone, including the recruitment of research and development (“R&D”) personnel
8-K
EX-99.1
GYRE
Gyre Therapeutics Inc
21 Feb 12
Targacept Reports Fourth Quarter and 2011 Financial Results
12:00am
treatment with TC-5214 as compared to placebo;
Recruitment continuing for the Phase 2b “switch” monotherapy study (known as the EXPLORER study) for patients …
Recruitment continuing in a Phase 2b potential registration study of AZD3480 head-to-head against donepezil in mild to moderate Alzheimer’s disease
8-K
EX-99.1
GYRE
Gyre Therapeutics Inc
9 May 07
Targacept Reports First Quarter 2007 Financial Results
12:00am
for research and development services and greater occupancy, salary and benefit, recruitment, supply and infrastructure costs incurred in connection
8-K
EX-99.1
GYRE
Gyre Therapeutics Inc
8 Nov 07
Targacept Reports Third Quarter 2007 Financial Results
12:00am
, salary and benefit, recruitment, service, supply and infrastructure costs incurred in connection with increased research and development activity.
General
8-K
EX-99.1
5q8f0mn0d3dcktjffaa
7 Aug 07
Targacept Reports Second Quarter 2007 Financial Results
12:00am
8-K
EX-99.1
lbnkmdyn3 172q9kv9v
5 Aug 08
Targacept Reports Second Quarter 2008 Financial Results
12:00am
8-K
EX-99.1
jx8rcakwgkd0r8xs
1 Nov 11
Targacept Reports Third Quarter 2011 Financial Results
12:00am
DEF 14A
3qjo u70nrri2
27 Apr 07
Definitive proxy
12:00am